Loading…

Relationship between transfusion volume and outcomes in children undergoing noncardiac surgery

BACKGROUND The objective of this study was to assess the relationship between the volume of red blood cells (RBCs) transfused and outcomes in children undergoing noncardiac surgery. STUDY DESIGN AND METHODS Children undergoing noncardiac surgery recorded in the 2012 and 2013 American College of Surg...

Full description

Saved in:
Bibliographic Details
Published in:Transfusion (Philadelphia, Pa.) Pa.), 2016-10, Vol.56 (10), p.2487-2494
Main Authors: Goobie, Susan M., DiNardo, James A., Faraoni, David
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND The objective of this study was to assess the relationship between the volume of red blood cells (RBCs) transfused and outcomes in children undergoing noncardiac surgery. STUDY DESIGN AND METHODS Children undergoing noncardiac surgery recorded in the 2012 and 2013 American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) pediatric databases were included. Outcomes included 30‐day mortality and the incidence of major postoperative complications. Children who received RBC transfusions were further classified into four subgroups based on the volume transfused. We used multivariable logistic regression analysis and propensity‐matched analysis to match each child who received a transfusion with a nontransfused control and to compare the incidences of 30‐day mortality and adverse postoperative outcomes. RESULTS After propensity‐matched analysis, there were 4496 children in the group that received transfusion volumes from 1 to 19 mL/kg, 1557 in the group that received volumes from 20 to 39 mL/kg, 506 in the group that received from 40 to 59 mL/kg, and 412 in the group that received ≥60 mL/kg. Children who received RBC transfusion volumes from 40 to 59 mL/kg and ≥60 mL/kg had an increased risk for 30‐day mortality of 7.3% versus 1.4% (p 
ISSN:0041-1132
1537-2995
DOI:10.1111/trf.13732